# Emergent BioSolutions Inc.: filings

EBS · NYSE · CIK 1367644 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/ebs.md) · [Financials](/companies/ebs/financials.md) · [Filings](/companies/ebs/filings.md) · [Insiders](/companies/ebs/insiders.md)

## Reports and events: 402 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 698, 8-K 299, CT ORDER 81, 10-Q 53, SC 13G/A 50, 3 30, 144 22, 10-K 18, DEF 14A 18, 4/A 16, DEFA14A 16, SC 13G 15, 425 13, UPLOAD 12, CORRESP 10, S-8 10, 8-K/A 8, ARS 7, EFFECT 5, 424B3 4, S-3ASR 3, SCHEDULE 13G 3, SCHEDULE 13G/A 3, 10-K/A 2, S-3 2, SEC STAFF LETTER 2, 10-Q/A 1, 3/A 1, 424B5 1, D 1, DEFR14A 1, NT 10-Q 1, POS AM 1, POS EX 1, PRE 14A 1, S-1 1, S-1/A 1, S-4 1, S-4/A 1, S-8 POS 1, SC 13D 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-16 | 11:48 ET | [8-K](/filings/0001367644-26-000098.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001367644-26-000098 |
| 2026-09-14 | 20:02 ET | [8-K](/filings/0001367644-26-000091.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001367644-26-000091 |
| 2026-09-01 | 20:13 ET | [8-K](/filings/0001367644-26-000088.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001367644-26-000088 |
| 2026-08-06 | 21:47 ET | [10-Q](/filings/0001367644-26-000082.md) | Quarterly report, period 2026-06-30 | 0001367644-26-000082 |
| 2026-08-05 | 20:06 ET | [8-K](/filings/0001367644-26-000080.md) | 2.02 Results of operations; 2.05 Exit or disposal costs; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001367644-26-000080 |
| 2026-06-29 | 15:14 ET | [8-K](/filings/0001367644-26-000068.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001367644-26-000068 |
| 2026-05-01 | 21:54 ET | [10-Q](/filings/0001367644-26-000065.md) | Quarterly report, period 2026-03-31 | 0001367644-26-000065 |
| 2026-04-30 | 20:32 ET | [8-K](/filings/0001367644-26-000059.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001367644-26-000059 |
| 2026-04-30 | 11:30 ET | [8-K](/filings/0001367644-26-000051.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001367644-26-000051 |
| 2026-04-17 | 21:51 ET | [8-K](/filings/0001367644-26-000038.md) | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001367644-26-000038 |
| 2026-03-20 | 20:51 ET | [DEF 14A](/filings/0001367644-26-000033.md) | Proxy statement, period 2025-12-31 | 0001367644-26-000033 |
| 2026-03-03 | 13:28 ET | [8-K](/filings/0001367644-26-000019.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001367644-26-000019 |
| 2026-02-27 | 22:46 ET | [10-K](/filings/0001367644-26-000015.md) | Annual report, period 2025-12-31 | 0001367644-26-000015 |
| 2026-02-26 | 21:08 ET | [8-K](/filings/0001367644-26-000012.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001367644-26-000012 |
| 2026-01-14 | 22:13 ET | [8-K](/filings/0001193125-26-013061.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-013061 |
| 2026-01-12 | 12:51 ET | [8-K](/filings/0001367644-26-000003.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001367644-26-000003 |
| 2025-12-12 | 13:29 ET | [8-K](/filings/0001367644-25-000207.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001367644-25-000207 |
| 2025-11-12 | 21:02 ET | [8-K](/filings/0001367644-25-000204.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001367644-25-000204 |
| 2025-10-30 | 21:38 ET | [10-Q](/filings/0001367644-25-000202.md) | Quarterly report, period 2025-09-30 | 0001367644-25-000202 |
| 2025-10-29 | 20:19 ET | [8-K](/filings/0001367644-25-000198.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001367644-25-000198 |
| 2025-09-11 | 20:07 ET | [8-K](/filings/0001367644-25-000188.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001367644-25-000188 |
| 2025-09-05 | 21:23 ET | [8-K](/filings/0001367644-25-000183.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001367644-25-000183 |
| 2025-08-07 | 21:50 ET | [10-Q](/filings/0001367644-25-000181.md) | Quarterly report, period 2025-06-30 | 0001367644-25-000181 |
| 2025-08-06 | 20:13 ET | [8-K](/filings/0001367644-25-000179.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001367644-25-000179 |
| 2025-06-24 | 20:09 ET | [8-K](/filings/0001367644-25-000153.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001367644-25-000153 |
| 2025-05-23 | 20:06 ET | [8-K](/filings/0001367644-25-000133.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001367644-25-000133 |
| 2025-05-08 | 21:46 ET | [10-Q](/filings/0001367644-25-000124.md) | Quarterly report, period 2025-03-31 | 0001367644-25-000124 |
| 2025-05-07 | 20:08 ET | [8-K](/filings/0001367644-25-000121.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001367644-25-000121 |
| 2025-05-06 | 20:19 ET | [8-K](/filings/0001367644-25-000114.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001367644-25-000114 |
| 2025-03-31 | 12:06 ET | [8-K](/filings/0001367644-25-000087.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001367644-25-000087 |
| 2025-03-24 | 21:34 ET | [8-K](/filings/0001367644-25-000083.md) | 8.01 Other events | 0001367644-25-000083 |
| 2025-03-21 | 20:37 ET | [DEF 14A](/filings/0001367644-25-000080.md) | Proxy statement, period 2024-12-31 | 0001367644-25-000080 |
| 2025-03-10 | 20:47 ET | [8-K](/filings/0001367644-25-000054.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001367644-25-000054 |
| 2025-03-04 | 22:41 ET | [10-K](/filings/0001367644-25-000021.md) | Annual report, period 2024-12-31 | 0001367644-25-000021 |
| 2025-03-03 | 21:27 ET | [8-K](/filings/0001367644-25-000019.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001367644-25-000019 |
| 2025-01-15 | 20:45 ET | [8-K](/filings/0001193125-25-007008.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-007008 |
| 2025-01-14 | 13:13 ET | [8-K](/filings/0001367644-25-000010.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001367644-25-000010 |
| 2025-01-08 | 22:12 ET | [8-K](/filings/0001367644-25-000004.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001367644-25-000004 |
| 2024-12-02 | 21:36 ET | [S-1/A](/filings/0001193125-24-268963.md) | Registration statement, amended | 0001193125-24-268963 |
| 2024-11-12 | 21:06 ET | [S-1](/filings/0001193125-24-255932.md) | Registration statement | 0001193125-24-255932 |
| 2024-11-07 | 22:46 ET | [10-Q](/filings/0001367644-24-000178.md) | Quarterly report, period 2024-09-30 | 0001367644-24-000178 |
| 2024-11-06 | 21:12 ET | [8-K](/filings/0001367644-24-000176.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001367644-24-000176 |
| 2024-10-04 | 11:29 ET | [8-K](/filings/0001367644-24-000161.md) | 5.02 Departure or appointment of officers or directors | 0001367644-24-000161 |
| 2024-10-02 | 12:11 ET | [8-K](/filings/0001193125-24-230710.md) | 1.01 Entry into a material agreement; 2.02 Results of operations; 2.03 New direct financial obligation; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-24-230710 |
| 2024-09-17 | 20:12 ET | [8-K](/filings/0001367644-24-000158.md) | 3.02 Unregistered sale of equity | 0001367644-24-000158 |
| 2024-09-03 | 11:47 ET | [8-K](/filings/0001193125-24-211548.md) | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-211548 |
| 2024-08-30 | 00:26 ET | [8-K](/filings/0001367644-24-000155.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001367644-24-000155 |
| 2024-08-20 | 20:20 ET | [8-K](/filings/0001367644-24-000152.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001367644-24-000152 |
| 2024-08-07 | 21:37 ET | [10-Q](/filings/0001367644-24-000147.md) | Quarterly report, period 2024-06-30 | 0001367644-24-000147 |
| 2024-08-06 | 20:21 ET | [8-K](/filings/0001367644-24-000142.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001367644-24-000142 |

Page 1 of 9. [Older](/companies/ebs/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:12 ET. No prices; not investment advice.